Enhancing photocatalytic degradation of beta-blocker drugs using TiO2 NPs/zeolite and ZnO NPs/zeolite as photocatalysts: optimization and kinetic investigations

Abstract This study delves into the development and optimization of photocatalysts, namely ZnO NPs/Zeolite and TiO2 NPs/Zeolite, for the degradation of two beta-blocker drugs, including Atenolol (AT) and Metoprolol (ME). Structural and morphological analyses of the catalysts were conducted, and opti...

Full description

Saved in:
Bibliographic Details
Main Authors: Sara Sarabyar, Afshin Farahbakhsh, Hamzeh Ali Tahmasebi, Behrooz Mahmoodzadeh Vaziri, Susan Khosroyar
Format: Article
Language:English
Published: Nature Portfolio 2024-11-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-024-73888-6
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850195860402470912
author Sara Sarabyar
Afshin Farahbakhsh
Hamzeh Ali Tahmasebi
Behrooz Mahmoodzadeh Vaziri
Susan Khosroyar
author_facet Sara Sarabyar
Afshin Farahbakhsh
Hamzeh Ali Tahmasebi
Behrooz Mahmoodzadeh Vaziri
Susan Khosroyar
author_sort Sara Sarabyar
collection DOAJ
description Abstract This study delves into the development and optimization of photocatalysts, namely ZnO NPs/Zeolite and TiO2 NPs/Zeolite, for the degradation of two beta-blocker drugs, including Atenolol (AT) and Metoprolol (ME). Structural and morphological analyses of the catalysts were conducted, and optimal conditions for drug degradation were determined using a Box-Behnken design. The results underscored the significant influence of pH, catalyst amount, drug concentration, and H2O2 concentration on the degradation process using ZnO NPs/Zeolite and TiO2 NPs/Zeolite as the catalysts. The optimal values of drug concentration, pH, catalyst amount, and H2O2 concentration, were determined to be 32 and 33 mg L−1, 4.2 and 4.6, 428 and 386 mg, and 2.6 and 2.5 mM utilizing ZnO NPs/Zeolite and TiO2 NPs/Zeolite as the catalyst, respectively. Following optimization, the kinetics of the photodegradation process were investigated, revealing promising rates and half-life times for both drugs. The pseudo-first-order rate constants for Atenolol and Metoprolol degradation were 0.064 ± 0.007 min−1 and 0.065 ± 0.004 min−1 with ZnO NPs/Zeolite and 0.071 ± 0.007 min−1 and 0.071 ± 0.006 min−1 with TiO2 NPs/Zeolite, respectively. Furthermore, ZnO NPs/Zeolite and TiO2 NPs/Zeolite demonstrated reusability up to 5 and 6 times, respectively, without significant activity loss. The comparative analysis highlighted the superior performance of TiO2 NPs/Zeolite over ZnO NPs/Zeolite, attributed to lower consumption, shorter degradation time, improved reusability, and compatibility with milder acidic conditions. Overall, the research showcases the potential of ZnO NPs/Zeolite and TiO2 NPs/Zeolite as an effective and sustainable solution for removing Metoprolol and Atenolol contaminants.
format Article
id doaj-art-89a789aabc024d5380f0ade83eaf12b9
institution OA Journals
issn 2045-2322
language English
publishDate 2024-11-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-89a789aabc024d5380f0ade83eaf12b92025-08-20T02:13:39ZengNature PortfolioScientific Reports2045-23222024-11-0114111810.1038/s41598-024-73888-6Enhancing photocatalytic degradation of beta-blocker drugs using TiO2 NPs/zeolite and ZnO NPs/zeolite as photocatalysts: optimization and kinetic investigationsSara Sarabyar0Afshin Farahbakhsh1Hamzeh Ali Tahmasebi2Behrooz Mahmoodzadeh Vaziri3Susan Khosroyar4Department of Chemical Engineering, Quchan Branch, Islamic Azad UniversityDepartment of Chemical Engineering, Quchan Branch, Islamic Azad UniversityDepartment of Chemical Engineering, Quchan Branch, Islamic Azad UniversityDepartment of Chemical Engineering, Quchan Branch, Islamic Azad UniversityDepartment of Chemical Engineering, Quchan Branch, Islamic Azad UniversityAbstract This study delves into the development and optimization of photocatalysts, namely ZnO NPs/Zeolite and TiO2 NPs/Zeolite, for the degradation of two beta-blocker drugs, including Atenolol (AT) and Metoprolol (ME). Structural and morphological analyses of the catalysts were conducted, and optimal conditions for drug degradation were determined using a Box-Behnken design. The results underscored the significant influence of pH, catalyst amount, drug concentration, and H2O2 concentration on the degradation process using ZnO NPs/Zeolite and TiO2 NPs/Zeolite as the catalysts. The optimal values of drug concentration, pH, catalyst amount, and H2O2 concentration, were determined to be 32 and 33 mg L−1, 4.2 and 4.6, 428 and 386 mg, and 2.6 and 2.5 mM utilizing ZnO NPs/Zeolite and TiO2 NPs/Zeolite as the catalyst, respectively. Following optimization, the kinetics of the photodegradation process were investigated, revealing promising rates and half-life times for both drugs. The pseudo-first-order rate constants for Atenolol and Metoprolol degradation were 0.064 ± 0.007 min−1 and 0.065 ± 0.004 min−1 with ZnO NPs/Zeolite and 0.071 ± 0.007 min−1 and 0.071 ± 0.006 min−1 with TiO2 NPs/Zeolite, respectively. Furthermore, ZnO NPs/Zeolite and TiO2 NPs/Zeolite demonstrated reusability up to 5 and 6 times, respectively, without significant activity loss. The comparative analysis highlighted the superior performance of TiO2 NPs/Zeolite over ZnO NPs/Zeolite, attributed to lower consumption, shorter degradation time, improved reusability, and compatibility with milder acidic conditions. Overall, the research showcases the potential of ZnO NPs/Zeolite and TiO2 NPs/Zeolite as an effective and sustainable solution for removing Metoprolol and Atenolol contaminants.https://doi.org/10.1038/s41598-024-73888-6Photodegradation methodBeta-blocker drugsZnO NPs/zeolite compositeTiO2 NPs/zeolite compositeBox-Behnken design
spellingShingle Sara Sarabyar
Afshin Farahbakhsh
Hamzeh Ali Tahmasebi
Behrooz Mahmoodzadeh Vaziri
Susan Khosroyar
Enhancing photocatalytic degradation of beta-blocker drugs using TiO2 NPs/zeolite and ZnO NPs/zeolite as photocatalysts: optimization and kinetic investigations
Scientific Reports
Photodegradation method
Beta-blocker drugs
ZnO NPs/zeolite composite
TiO2 NPs/zeolite composite
Box-Behnken design
title Enhancing photocatalytic degradation of beta-blocker drugs using TiO2 NPs/zeolite and ZnO NPs/zeolite as photocatalysts: optimization and kinetic investigations
title_full Enhancing photocatalytic degradation of beta-blocker drugs using TiO2 NPs/zeolite and ZnO NPs/zeolite as photocatalysts: optimization and kinetic investigations
title_fullStr Enhancing photocatalytic degradation of beta-blocker drugs using TiO2 NPs/zeolite and ZnO NPs/zeolite as photocatalysts: optimization and kinetic investigations
title_full_unstemmed Enhancing photocatalytic degradation of beta-blocker drugs using TiO2 NPs/zeolite and ZnO NPs/zeolite as photocatalysts: optimization and kinetic investigations
title_short Enhancing photocatalytic degradation of beta-blocker drugs using TiO2 NPs/zeolite and ZnO NPs/zeolite as photocatalysts: optimization and kinetic investigations
title_sort enhancing photocatalytic degradation of beta blocker drugs using tio2 nps zeolite and zno nps zeolite as photocatalysts optimization and kinetic investigations
topic Photodegradation method
Beta-blocker drugs
ZnO NPs/zeolite composite
TiO2 NPs/zeolite composite
Box-Behnken design
url https://doi.org/10.1038/s41598-024-73888-6
work_keys_str_mv AT sarasarabyar enhancingphotocatalyticdegradationofbetablockerdrugsusingtio2npszeoliteandznonpszeoliteasphotocatalystsoptimizationandkineticinvestigations
AT afshinfarahbakhsh enhancingphotocatalyticdegradationofbetablockerdrugsusingtio2npszeoliteandznonpszeoliteasphotocatalystsoptimizationandkineticinvestigations
AT hamzehalitahmasebi enhancingphotocatalyticdegradationofbetablockerdrugsusingtio2npszeoliteandznonpszeoliteasphotocatalystsoptimizationandkineticinvestigations
AT behroozmahmoodzadehvaziri enhancingphotocatalyticdegradationofbetablockerdrugsusingtio2npszeoliteandznonpszeoliteasphotocatalystsoptimizationandkineticinvestigations
AT susankhosroyar enhancingphotocatalyticdegradationofbetablockerdrugsusingtio2npszeoliteandznonpszeoliteasphotocatalystsoptimizationandkineticinvestigations